These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 38441582)

  • 21. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
    Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counseling Family Members and Monitoring for Evidence of Disease in Asymptomatic Carriers of Amyloid Transthyretin Cardiac Amyloidosis.
    Barker N; Judge DP
    Am J Cardiol; 2022 Dec; 185 Suppl 1():S43-S50. PubMed ID: 36216601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.
    Park GY; Jamerlan A; Shim KH; An SSA
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATTR Epidemiology, Genetics, and Prognostic Factors.
    Obi CA; Mostertz WC; Griffin JM; Judge DP
    Methodist Debakey Cardiovasc J; 2022; 18(2):17-26. PubMed ID: 35414855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin: Its function and amyloid formation.
    Ueda M
    Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac transthyretin amyloidosis.
    Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
    Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Illustrative review of cardiac amyloidosis by multimodality imaging.
    Tanaka H
    Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones.
    Capovilla TM; Lalario A; Rossi M; Porcari A; Aimo A; Limongelli G; Emdin M; Merlo M; Sinagra G
    Heart Fail Clin; 2024 Jul; 20(3):333-341. PubMed ID: 38844304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurological manifestations of ATTR amyloidosis].
    Pernice HF; Hahn K
    Inn Med (Heidelb); 2023 Sep; 64(9):848-854. PubMed ID: 37555967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
    Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
    JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States.
    Lau ATC; DiDomenico RJ; Kim K
    Int J Cardiol; 2024 Mar; 398():131598. PubMed ID: 37979789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin cardiac amyloidosis.
    Porcari A; Fontana M; Gillmore JD
    Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
    Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
    JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.
    Ono R; Takahashi H; Sato T; Yamazaki T; Hori Y; Fukushima K
    J Cardiol Cases; 2020 Nov; 22(5):221-225. PubMed ID: 33133314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy.
    Park J; Egolum U; Parker S; Andrews E; Ombengi D; Ling H
    Ann Pharmacother; 2020 May; 54(5):470-477. PubMed ID: 31735059
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A; Sabogal N; Massillon D; Paul LD; Rodriguez C; Fine D; Helmke S; Winburn M; Kurian D; Raiszadeh F; Teruya S; Cohn E; Einstein AJ; Miller EJ; Connors LH; Maurer MS; Ruberg FL
    J Am Heart Assoc; 2023 Aug; 12(15):e028973. PubMed ID: 37486082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and therapeutic approaches to transthyretin amyloidosis.
    Ando Y; Ueda M
    Curr Med Chem; 2012; 19(15):2312-23. PubMed ID: 22471980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans.
    Jacobson DR; Alexander AA; Tagoe C; Buxbaum JN
    Amyloid; 2015; 22(3):171-4. PubMed ID: 26123279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.